Debates

COVID-19 May Briefing: The UK&I Healthcare Ecosystem Fightback

https://pharmaphorum.com/r-d/covid-19-may-briefing-the-uki-healthcare-ecosystem-fightback/

The new global digital health paradigm in life sciences

https://pharmaphorum.com/r-d/10-years-in-10-days-the-new-global-digital-health-paradigm-in-life-sciences/

COVID-19 briefing: coronavirus impacts for UK and Ireland pharma and biotech

https://pharmaphorum.com/r-d/iqvia-covid-19-april-briefing-impact-for-pharma-and-biotech/

Vaccines trials in the COVID-19 era and tech’s role in speeding studies

https://pharmaphorum.com/r-d/vaccines-trials-covid-19-coronavirus/

The COVID-19 coronavirus and pharma and biotech continuity planning

https://pharmaphorum.com/r-d/the-potential-impact-of-coronavirus-covid-19-for-global-pharma-and-biotech-continuity/

Digital health: how can technology be used to engage hard-to-reach patients and assist with patient monitoring?

https://pharmaphorum.com/debates-insight-digital/digital-health-can-technology-used-engage-hard-reach-patients-assist-patient-monitoring/

20/06/2017

Disruption and maturity: the future directions for biologics

https://pharmaphorum.com/debates-insight-market-access/disruption-maturity-future-directions-biologics/

The future of the clinical trial: collaboration and patient centricity

https://pharmaphorum.com/debates-insight-patients/future-clinical-trial-collaboration-patient-centricity/

10/03/2017

Approval and access: overcoming the final hurdle of drug development

https://pharmaphorum.com/debates-insight-market-access/european-market-access-overcoming-final-hurdle-drug-development/

1 2

Close in 10 seconds

Pharmaphorum.com

Search